Chul Ahn
University of Texas Southwestern Medical Center
H-index: 82
North America-United States
Top articles of Chul Ahn
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A Bayesian adaptive design approach for stepped-wedge cluster randomized trials | Clinical Trials | Jijia Wang Jing Cao Chul Ahn Song Zhang | 2024/1/19 |
Candida dubliniensis in Japanese Oral Microbiota: A Cross-Sectional Study of Six Geographic Regions in Japan | Microorganisms | Tomoko Ohshima Yoko Mukai Hitoshi Watanabe Keijiro Ohshima Koichi Makimura | 2024/3/5 |
Rapid Start of Antiretroviral Therapy in a Large Urban Clinic in the US South: Impact on HIV Care Continuum Outcomes and Medication Adherence | Journal of the International Association of Providers of AIDS Care (JIAPAC) | Jeremy Y Chow Ang Gao Chul Ahn Ank E Nijhawan | 2024/1 |
Association Between Substance Abuse and Mental Illness Symptoms Screener (SAMISS) Scores and HIV Care Continuum Outcomes in People Newly Diagnosed with HIV in the US South | AIDS and Behavior | Manal Ahmed Ank E Nijhawan Ang Gao Chul Ahn Jeremy Y Chow | 2024/2/16 |
HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell Carcinoma | International Journal of Radiation Oncology* Biology* Physics | Dominic H Moon Vladimir Avkshtol Dat Vo Chul Ahn Baran Sumer | 2024/1/1 |
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial | Nature communications | David Hsiehchen Muhammad S Beg Radhika Kainthla Jay Lohrey Syed M Kazmi | 2024/3/11 |
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non–Small Cell Lung Cancer | American Journal of Clinical Oncology | Christian M Alvarez Maureen Aliru Bhavani S Gannavarapu Tidie Song Linda Anne Gilmore | 2024/2/1 |
Tumor loss-of-function mutations in STK11/LKB1 induce cachexia | JCI insight | Puneeth Iyengar Aakash Y Gandhi Jorge Granados Tong Guo Arun Gupta | 2023/4/4 |
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer | Lung Cancer | Sheena Bhalla Farjana J Fattah Chul Ahn Jessica Williams Alyssa Macchiaroli | 2023/8/1 |
Phase I Trial of ‘Re-Priming’Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy | International Journal of Radiation Oncology, Biology, Physics | KA Kumar R Ravella P Ramakrishnan Geethakumari F Awan TA Aguilera | 2023/10/1 |
Maximum dose, safety, tolerability and ketonemia after triheptanoin in glucose transporter type 1 deficiency (G1D) | Scientific reports | Ignacio Málaga Adrian Avila Sharon Primeaux Raja Reddy Kallem Charles R Roe | 2023/3/1 |
Characteristics and clinical outcomes in young‐onset cholangiocarcinoma | Cancer Medicine | Sarah Reddy Suleyman Yasin Goksu Nina N Sanford Radhika Kainthla David Hsiehchen | 2023/7 |
Financial Toxicity and Patient Experience Outcomes on a Multi-Institutional Phase I Single Fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer | International Journal of Radiation Oncology, Biology, Physics | A Simmons DJ Sher N Kim M Leitch JA Haas | 2023/10/1 |
Abstract P6-05-55: Financial Toxicity Outcomes on a Phase I 5-fraction Partial Breast Irradiation Protocol for Early Stage Breast Cancer | Cancer Research | Ambrosia Simmons David Sher Dong W Nathan Kim Marilyn Leitch Rachel Wooldridge | 2023/3/1 |
PHASE I TRIAL OF ‘RE‐PRIMING’RADIATION THERAPY FOR RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS IN INCOMPLETE RESPONSE AFTER CAR‐T THERAPY | Hematological Oncology | P Ramakrishnan Geethakumari R Ravella FT Awan E Yilmaz HR Wolfe | 2023/6 |
Within-person associations of optimistic and pessimistic expectations with momentary stress, affect, and ambulatory blood pressure | Anxiety, Stress, & Coping | John M Felt Michael A Russell Jillian A Johnson John M Ruiz Bert N Uchino | 2023/9/3 |
Abstract OT2-17-01: Phase 1 trial of anthracycline chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple-negative breast cancer | Cancer Research | Sangeetha Reddy Meredith Carter Isaac Chan Nisha Unni Namrata Peswani | 2023/3/1 |
Association of cachexia with loss of function mutations in STK11/LKB1 for NSCLC. | Rodney E Infante Chul Ahn John D Minna Puneeth Iyengar | 2023/6/1 | |
Efficacy and quality-of-life following involved nodal radiotherapy for head and neck squamous cell carcinoma: the INRT-AIR phase II clinical trial | Clinical Cancer Research | David J Sher Dominic H Moon Dat Vo Jing Wang Liyuan Chen | 2023/6/26 |
Radiation-Induced Innate Neutrophil Response in Tumor Is Mediated by the CXCLs/CXCR2 Axis | Cancers | Faya Zhang Oscar Mulvaney Erica Salcedo Subrata Manna James Z Zhu | 2023/12/1 |
